300 billion big white horses fell 7%!The Shanghai Index lost 3100 points ... The big fund anti -corruption, some chairman of A -share lost contact?Company response

Author:Broker China Time:2022.09.21

Source: Securities Times ID: wwwstcncom

The A -share market fell further this morning, and the Shanghai Index fell below 3100 points, and then picked up. As of the close, the Shanghai Index fell slightly by 0.17%; the Shenzhen Stock Exchange Index fell 0.67%; the GEM index fell 1.49%.

This morning, the market's individual stocks performed flat, but there were still violent fluctuations in stocks. For example, the market value of white horse stocks with a market value of more than 300 billion yuan fell more than 8%in the market, as of the closing of 7.21%as of the close.

In addition, the performance of the new shares today is also severely differentiated. Of the four new shares listed today, three of the mornings were broken in the morning, and the largest decline in the market exceeded 10%.

The Shanghai Index once fell below 3100 points

The A -share market fell again this morning, and the main stock index fell. The Shanghai Stock Exchange Index fell below 3100 points, which was as low as 3091.30 points, but later received 3100 intersectors. The deep syndromes and the GEM index have once reached the stage low.

The market value of more than 300 billion yuan of medical equipment leader Mai Rui medical treatment fell significantly by 7.85%, and the stock market fell more than 8%. As of the closing of 7.21%.

The decline of the home furnishing sector was close to 3%. Tourism and hotel catering sectors have fallen first.

Caitong Securities ’recent research views believe that the hotel industry has strong store development capabilities and high brand premiums. It will fully enjoy the growth attributes of the high -speed expansion and price improvement of the store in the long run. The recovery of business travel demand. It is recommended to pay attention to head hotel standards with high domestic market share.

Transportation services, gas supply, heating, power, and transportation facilities have risen against the trend.

As of the close, Wanye enterprises fell slightly by 0.19%, and the stock price was reported at 21.44 yuan/share. Some investors asked on the interactive platform, "The market rumors are rumored to be temporarily lost contact due to the big fund incident?" Wanye Enterprise said that the company's chairman and all executives are in normal performances and are currently operating normal.

3 new stocks broke on the first day of the market

Today, there are 4 new shares on the A -share market. On the first day of the listing, the performance of the listing again appeared again. Both exceeded 10%, but another new stock Ensi Medical disk rose sharply.

The market data shows that Nuo Chengjian was as low as 9.01 yuan in the market this morning. According to this calculation, the floating loss in the new stock market for the new stocks reached 1010 yuan. According to the prospectus, Nuo Chengjian is an innovative biomedical enterprise with excellent independent research and development capabilities as its core driving force. It has comprehensive research and development and commercialization capabilities. The field of fields in the global market develops the best or first -pioneering drugs with breakthrough potential. As of the date of signing the prospectus, one of the company's main products Obutinib (Yi Nuokai®) has been approved to be listed by the Conditions of the State Drug Administration in December 2020. TAFASITAMAB has been approved at the Boao Super Hospital as a clinical urgent need to import imports. Pharmaceutical use, 13 products are in the clinical trial stage of stage I/II/III, and 3 products are in the pre -clinical stage. The company is promoting the clinical trials and registration of products in the global market, which is dominated by China and the United States, to realize the clinical trials and registration of products to achieve candidate drugs in the product pipeline.

Michigani Technology was as low as 28.20 yuan this morning. According to this calculation, the floating loss in the new stock market for the new stock market reached 2,350 yuan. The prospectus shows that the main business of magnetic valley technology is the research and development, production, and sales of magnetic suspension fluid machinery and magnetic suspension bearings, high -speed motors, and high -speed drivers. The main products of the issuer are magnetic suspended centrifugal fan, magnetic suspension air compressor, and magnetic suspension cold water units. They have technical advantages such as no mechanical contact, high -speed efficiency, energy saving and other technical advantages. , Machinery manufacturing, construction and other industries. The company is expected to achieve operating income of 163 million yuan to 170 million yuan from January to September 2022, a year-on-year change of -0.86%to 3.40%. It is expected that the net profit attributable to shareholders of the parent company is 19.5 million yuan to 23.5 million yuan, a year-on-year change of -16.24 %To 0.94%, it is expected that the net profit attributable to shareholders of the parent company after deducting non -recurring profit or loss is 14.6 million yuan to 15.3 million yuan, a year -on -year decrease of 14.50%to 18.41%.

The Bangbang Technology was as low as 46.50 yuan this morning. According to this calculation, the floating loss in the new stock market for the new stock market reached 2610 yuan. According to the prospectus, Gezang Technology can provide customers with a customized precision functional and structural parts production service provider, which can provide customers with a series of services including product design and development, material selection verification, mold design, trial production, testing, mass production and other services. After years of development, the product category of the company's precision functional parts and structural parts has transitioned from traditional precision functional parts through protective functional parts, and developed to flexible composite precision functional parts and metal precision functional structures. , All -in -one computers, smart home, 3D printing, drone and other consumer electronics products fields; at the same time, the company has also extended to the field of new materials to develop carbon nanotimal products with relative advantages in mechanics and conductivity. Lithium battery field.

The minimum prices in the above three new stocks have fallen by 10%compared with the issue price this morning, of which the minimum price of Nuocheng Jianhua fell more than 18%compared with the issuance price.The performance of new shares Enwei Medicine is another scene.The market data shows that Enwei Pharmaceutical performed strongly this morning, and once rose to 50.10 yuan in the market. According to this calculation, China One signed a new stock market for more than 10,000 yuan.The prospectus shows that Enwei Pharmaceutical is mainly engaged in the research and development, production and sales of Chinese medicine and chemical drugs, and focuses on gynecological products, pediatric drugs, respiratory drugs and other fields.The company established a production system in accordance with GMP requirements, and adopted a sales model based on the distribution model, supplemented by direct sales and e -commerce as the supplemented.The company has been cultivating in the field of gynecological products for many years. Data from Mine.com shows that from 2017-2021, the core product "Jieer Yin Washing" ranked first in the market share of gynecological inflammation in China's urban retail pharmacy.

Editor -in -chief: Wang Lulu